Atrion Corporation

459.92
0.26 (0.06%)
At close: Aug 20, 2024, 8:00 PM

Company Description

Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Canada, Europe, and internationally.

Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments.

The company's cardiovascular products comprise Myocardial Protection System that delivers fluids and medications and mixes critical drugs, as well as controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery.

Its ophthalmic products include specialized medical devices that disinfect contact lenses; and a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults.

The company also manufactures instrumentation and associated disposables that measure the activated clotting time of blood; and products for safe needle and scalpel blade containment.

In addition, it manufactures inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; and one-way and two-way pressure relief valves that protect sensitive electronics and other products during transport in other medical and non-medical applications.

The company sells its products to physicians, hospitals, clinics, and other treatment centers; and other equipment manufacturers through direct sales force, independent sales representatives, and distributors.

Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.

Atrion Corporation
Atrion Corporation logo
Country United States
IPO Date Mar 18, 1980
Industry Medical - Instruments & Supplies
Sector Healthcare
Employees 712
CEO David A. Battat

Contact Details

Address:
One Allentown Parkway
Allen, Texas
United States
Website https://www.atrioncorp.com

Stock Details

Ticker Symbol ATRI
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0000701288
CUSIP Number 049904105
ISIN Number US0499041053
Employer ID 63-0821819
SIC Code 3841

Key Executives

Name Position
David A. Battat President & Chief Executive Officer
Cindy Ferguson Vice President, Chief Financial Officer, Secretary & Treasurer
Emile A. Battat Executive Chairman

Latest SEC Filings

Date Type Title
Nov 14, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Sep 09, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Sep 03, 2024 15-12G Filing
Aug 22, 2024 SC 13D/A [Amend] Filing
Aug 22, 2024 SC 13D/A [Amend] Filing
Aug 22, 2024 SC 13D/A [Amend] Filing
Aug 22, 2024 SC 13D/A [Amend] Filing
Aug 21, 2024 4 Filing
Aug 21, 2024 4 Filing
Aug 21, 2024 4 Filing